News

Eli Lilly (LLY) has recently shared positive developments in its innovative therapies, reporting significant progress with ...
DelveInsight's,“ Chronic Heart Failure Pipeline Insight, 2025 ” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Chronic Heart Failure pipeline landscape. It covers ...
Eli Lilly drug Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the ...
AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI's impact in ...